Optimizing Biotech & CRO Collaboration in Early Drug Discovery Trends, Challenges, and Solutions
Watch this insightful webinar on optimizing the collaboration between biotech companies and contract research organizations (CROs) in early drug discovery. As pharmaceutical innovation continues to be driven by small to midsize biotechs, the strategic outsourcing of research and development activities to CROs has become crucial for navigating the challenges faced by these companies. This webinar explores the latest trends and challenges in early drug discovery outsourcing, backed by research and survey findings commissioned by Dotmatics from C&EN BrandLab. We dive into the evolving role of CROs and discuss how biotech-CRO collaboration can be optimized to achieve maximum efficiency and success. Learn more: https://www.dotmatics.com/whitepapers...

Data-Driven R&D in Chemicals & Materials: Why an Open Platform is Essential

IHSCM Showcase: Optimisation to Improve Surgical Waitlist Management

Digital Pharma Marketing Trends Shaping 2023

Machine Learning: A new approach to drug discovery

Protecting Your Secret Sauce: Trade Secrets in the Modern Workplace

An Introduction to Computational Drug Discovery

Managing The Clinical Research Process From Start Up to Close Out

Preparing for Crypto Compliance Webinar

The SaaS business model & metrics: Understand the key drivers for success

Webinar | Session 3: Innovation, Infrastructure and the Digital Economy

SEFI@work | The Engineering Skills Position Paper – The Industry Response

How to Plan Your Content Journey Across SharePoint, Purview, and Preservew365 | Gravity Union

Using AI-driven Drug Design to Shorten Your Drug Development Process

Fixing the Operational Gaps That Undermine Subscription Profitability | CDS Global

How fast-moving EU rules are reshaping the future of EPDs and product data globally

What’s Holding Back AI in Drug Discovery?; Kfir Schreiber

Polygon U.S. Crypto Hearing | Here's What's at Stake

Climate Budget Training Course | Module 4: Analysing costs and benefits

Moderna Co-Founder and Flagship Pioneering CEO on the Future of Biotech | WSJ News

